Regeneron Pharmaceuticals Aktie
826,70
EUR
-38,70
EUR
-4,47
%
934,65
USD
+3,89
USD
+0,42
%
Erwachsen handeln.
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Werbung
Regeneron Pharmaceuticals Aktie Analyse
| 20.10.17 | Regeneron Pharmaceuticals Underweight | Barclays Capital | |
| 01.08.17 | Regeneron Pharmaceuticals Underperform | Robert W. Baird & Co. Incorporated | |
| 07.11.16 | Regeneron Pharmaceuticals Sell | Chardan Capital Markets | |
| 16.03.16 | Regeneron Pharmaceuticals Sell | Chardan Capital Markets | |
| 25.01.16 | Regeneron Pharmaceuticals Sell | Chardan Capital Markets | |
| 05.08.15 | Regeneron Pharmaceuticals Sell | UBS AG | |
| 11.01.05 | Regeneron Pharmaceuticals Sell | Banc of America Sec. |
Werbung
Werbung